
Galen Partners
Description
Galen Partners is a healthcare-focused private equity firm established in 1990, based in Stamford, Connecticut. Unlike traditional early-stage venture capital, Galen specializes in growth equity investments, recapitalizations, and buyouts within the healthcare sector. Their investment strategy targets established, often profitable, lower middle-market companies seeking capital for expansion, strategic acquisitions, or ownership transitions across various sub-sectors, including healthcare services, medical devices, diagnostics, and healthcare information technology.
The firm's approach emphasizes active collaboration with management teams, leveraging its deep industry expertise and extensive network to drive growth and operational improvements. Galen seeks to identify companies with strong market positions, proven business models, and significant growth potential. They provide not just capital but also strategic guidance, operational support, and assistance with M&A activities, aiming to build market leaders. Their long history in the healthcare space allows them to bring valuable insights to their portfolio companies, fostering sustainable value creation.
Galen Partners typically makes initial investments ranging from approximately $10 million to $50 million, though they have the capacity for larger commitments through co-investments or follow-on rounds, potentially reaching up to $75 million or more in total capital deployed per company. For instance, their Galen Partners VI fund closed with $340 million in commitments, demonstrating their substantial capital base for investments. Over their three decades of operation, they have invested in over 70 healthcare companies, contributing significantly to growth and innovation within the industry.
Investor Profile
Galen Partners has backed more than 25 startups, with 0 new investments in the last 12 months alone. The firm has led 11 rounds, about 44% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Hospital.
- Typical check size: $10M – $50M.
Stage Focus
- Series Unknown (40%)
- Series C (28%)
- Series D (12%)
- Post Ipo Equity (8%)
- Series B (8%)
- Convertible Note (4%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Hospital
- Manufacturing
- Biotechnology
- Software
- Information Technology
- Medical
- Pharmaceutical
- Mobile
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.